Drug Shortage Report for TARO-QUETIAPINE
| Report ID | 33277 |
| Drug Identification Number | 02397099 |
| Brand name | RAN-QUETIAPINE |
| Common or Proper name | RAN-QUETIAPINE |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | QUETIAPINE |
| Strength(s) | 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-11-23 |
| Actual start date | 2018-11-23 |
| Estimated end date | 2019-04-26 |
| Actual end date | 2019-04-12 |
| Shortage status | Resolved |
| Updated date | 2019-04-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.